ISL
CL icon

Ingalls & Snyder LLC’s Colgate-Palmolive CL Stock Holding History

Ingalls & Snyder LLC’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2M Hold
23,523
– – 0.07% 153
2025
Q4 		$1.86M Hold
23,523
– – 0.07% 166
2025
Q3 		$1.88M Sell
23,523
-34
-0.1% -$2.9K 0.06% 164
2025
Q2 		$2.14M Hold
23,557
– – 0.08% 154
2025
Q1 		$2.21M Hold
23,557
– – 0.07% 145
2024
Q4 		$2.14M Buy
23,557
+282
+1% +$26.9K 0.08% 142
2024
Q3 		$2.42M Sell
23,275
-26
-0.1% -$2.65K 0.09% 137
2024
Q2 		$2.26M Sell
23,301
-10
-0% -$922 0.1% 132
2024
Q1 		$2.1M Hold
23,311
– – 0.09% 136
2023
Q4 		$1.86M Sell
23,311
-500
-2% -$37.6K 0.08% 149
2023
Q3 		$1.69M Buy
23,811
+870
+4% +$65K 0.08% 155
2023
Q2 		$1.77M Hold
22,941
– – 0.08% 152
2023
Q1 		$1.72M Buy
22,941
+59
+0.3% +$4.39K 0.09% 151
2022
Q4 		$1.8M Hold
22,882
– – 0.1% 141
2022
Q3 		$1.61M Hold
22,882
– – 0.09% 150
2022
Q2 		$1.83M Buy
22,882
+130
+0.6% +$10.2K 0.1% 149
2022
Q1 		$1.73M Hold
22,752
– – 0.08% 164
2021
Q4 		$1.94M Sell
22,752
-180
-0.8% -$14.1K 0.09% 163
2021
Q3 		$1.73M Buy
22,932
+215
+0.9% +$17.1K 0.08% 177
2021
Q2 		$1.85M Sell
22,717
-2,000
-8% -$164K 0.08% 175
2021
Q1 		$1.95M Sell
24,717
-717
-3% -$56.2K 0.09% 160
2020
Q4 		$2.17M Sell
25,434
-6,133
-19% -$507K 0.11% 148
2020
Q3 		$2.44M Buy
31,567
+1,000
+3% +$76.2K 0.17% 109
2020
Q2 		$2.24M Buy
30,567
+900
+3% +$63.9K 0.13% 123
2020
Q1 		$1.97M Sell
29,667
-19,641
-40% -$1.39M 0.13% 124
2019
Q4 		$3.39M Sell
49,308
-2,295
-4% -$156K 0.18% 103
2019
Q3 		$3.79M Sell
51,603
-6,394
-11% -$464K 0.19% 107
2019
Q2 		$4.16M Sell
57,997
-52,212
-47% -$3.71M 0.2% 98
2019
Q1 		$7.55M Sell
110,209
-616
-0.6% -$39.8K 0.36% 72
2018
Q4 		$6.6M Sell
110,825
-24,908
-18% -$1.56M 0.35% 73
2018
Q3 		$9.09M Sell
135,733
-2,448
-2% -$163K 0.38% 67
2018
Q2 		$8.96M Sell
138,181
-840
-0.6% -$54.9K 0.42% 66
2018
Q1 		$9.96M Sell
139,021
-1,301
-0.9% -$93.6K 0.49% 56
2017
Q4 		$10.6M Sell
140,322
-4,032
-3% -$294K 0.49% 51
2017
Q3 		$10.5M Sell
144,354
-2,197
-1% -$158K 0.55% 46
2017
Q2 		$10.9M Sell
146,551
-351
-0.2% -$26.1K 0.59% 44
2017
Q1 		$10.8M Buy
146,902
+3,551
+2% +$249K 0.57% 44
2016
Q4 		$9.38M Sell
143,351
-617
-0.4% -$42.3K 0.51% 48
2016
Q3 		$10.7M Sell
143,968
-2,337
-2% -$173K 0.6% 42
2016
Q2 		$10.7M Buy
146,305
+7,288
+5% +$519K 0.63% 42
2016
Q1 		$9.82M Sell
139,017
-1,265
-0.9% -$84.2K 0.62% 42
2015
Q4 		$9.35M Sell
140,282
-2,581
-2% -$172K 0.6% 42
2015
Q3 		$9.07M Sell
142,863
-4,418
-3% -$289K 0.59% 45
2015
Q2 		$9.63M Sell
147,281
-1,203
-0.8% -$81.6K 0.53% 44
2015
Q1 		$10.3M Sell
148,484
-1,193
-0.8% -$82.5K 0.57% 40
2014
Q4 		$10.4M Sell
149,677
-1,097
-0.7% -$74.1K 0.6% 38
2014
Q3 		$9.83M Sell
150,774
-961
-0.6% -$63.4K 0.53% 44
2014
Q2 		$10.3M Sell
151,735
-2,507
-2% -$168K 0.51% 43
2014
Q1 		$10M Buy
154,242
+580
+0.4% +$36.5K 0.54% 42
2013
Q4 		$10M Sell
153,662
-5,960
-4% -$381K 0.55% 45
2013
Q3 		$9.46M Buy
159,622
+1,872
+1% +$111K 0.57% 43
2013
Q2 		$9.04M Buy
+157,750
New +$9.36M 0.58% 44

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ingalls & Snyder LLC's CL Position: Q1 2026 in Review

Ingalls & Snyder LLC held its Colgate-Palmolive (CL) position steady in Q1 2026 at 23,523 shares worth $2M. The position accounts for 0.07% of the portfolio, ranked #153.

Ingalls & Snyder LLC first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $10.9M in Q2 2017. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Ingalls & Snyder LLC held 23,523 shares of Colgate-Palmolive worth $2M as of Q1 2026.
  • Ingalls & Snyder LLC left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.07% of Ingalls & Snyder LLC's portfolio in Q1 2026, its #153 holding.
  • Ingalls & Snyder LLC first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Ingalls & Snyder LLC's Colgate-Palmolive position peaked at $10.9M in Q2 2017.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2026, filed 13 May 2026.